Validation of an Automatic Analysis Algorithm of the Probability of Glaucoma From Optic Disc Images
1 other identifier
observational
615
1 country
1
Brief Summary
Clinical, cross-sectional and prospective study to assess the images of the posterior pole of the retina of patients from the Glaucoma Unit of the IOBA and the Hospital Clínico Universitario de Valladolid during the period between May and December 2021. The aim of the project is to provide a sufficient number of images from posterior pole retinographies in patients with suspected glaucoma or with diagnosis of glaucoma in order to determine the sensitivity and specificity of an automatic glaucoma screening algorithm developed by the company Transmural Biotech S.L.
Trial Health
Trial Health Score
Automated assessment based on enrollment pace, timeline, and geographic reach
participants targeted
Target at P75+ for all trials
Started May 2021
Shorter than P25 for all trials
1 active site
Health score is calculated from publicly available data and should be used for screening purposes only.
Trial Relationships
Click on a node to explore related trials.
Study Timeline
Key milestones and dates
Study Start
First participant enrolled
May 7, 2021
CompletedFirst Submitted
Initial submission to the registry
July 12, 2021
CompletedFirst Posted
Study publicly available on registry
July 22, 2021
CompletedPrimary Completion
Last participant's last visit for primary outcome
February 23, 2022
CompletedStudy Completion
Last participant's last visit for all outcomes
February 23, 2022
CompletedFebruary 28, 2022
February 1, 2022
10 months
July 12, 2021
February 25, 2022
Conditions
Keywords
Outcome Measures
Primary Outcomes (1)
Sensitivity and Specificity of an automated classification system for retinographies
Day 0
Study Arms (2)
Glaucoma
People with diagnosis of Primary Open Angle Glaucoma (POAG)
Ocular Hypertension / glaucoma suspect
People with diagnosis of Ocular Hypertension or POAG suspicion
Interventions
Fundus photographs under mydriasis
Eligibility Criteria
Ocular hypertensive patients or patients with diagnosis of Glaucoma.
You may qualify if:
- Primary open angle glaucoma or ocular hypertension
- Signed informed consent
- Visual field examination within the last 12 months
You may not qualify if:
- Ocular or systemic pathologies that may interfere with the quality of the retinographic image or the results of the visual field
- Congenital anomalies of the papilla that seriously alter its structure
- High ametropia (\> 10 diopters)
- Pharmacological Mydriasis contraindication.
Contact the study team to confirm eligibility.
Sponsors & Collaborators
Study Sites (1)
IOBA - Universidad de Valladolid
Valladolid, 47011, Spain
MeSH Terms
Conditions
Condition Hierarchy (Ancestors)
Study Design
- Study Type
- observational
- Observational Model
- COHORT
- Time Perspective
- PROSPECTIVE
- Sponsor Type
- OTHER
- Responsible Party
- SPONSOR
Study Record Dates
First Submitted
July 12, 2021
First Posted
July 22, 2021
Study Start
May 7, 2021
Primary Completion
February 23, 2022
Study Completion
February 23, 2022
Last Updated
February 28, 2022
Record last verified: 2022-02